Scar Treatment Market Size will Observe Substantial Growth by 2027

According to a new market report published by Transparency Market Research “Scar Treatment Market (By Scar Type: Atrophic & Acne Scars, Hypertrophic Scars and Keloids, Contracture Scars, Others (Stretch Marks), By treatment type (Topical Products (Creams, Gels, Silicone Sheets, Others (Sprays, Oils, etc.)), Laser Treatment (CO2 Lasers, Pulsed Dye Laser, Excimer Laser), Injectables, Others, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019 – 2027”. According to the report, the global scar treatment market was valued at US$ 15,805.4 Mn in 2019 and is projected to reach US$ 32,141.8 Mn by 2027, expanding at a high CAGR of 8.3% from 2019 to 2027. Increase in number of people suffering from skin problems across the world is anticipated to fuel the global scar treatment market during the forecast period.

Overview

• Scars are likely to have major consequences on an individual’s life with respect to appearance, over all well-being, and satisfaction with surgical procedures, especially when scars appear on sensitive parts or places of the body and cannot be covered by clothes.
• The scar treatment and cosmetic intervention industries are fragmented across the world. Development has been taking place in pockets where there is ample affordability.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12509

Increase in Incidence of Atrophic & Acne Scars and Hypertrophic Scars and Keloids to Boost Market

• In terms of scar type, the atrophic & acne scars segment is projected to account for a dominant share of the global scar treatment market during the forecast period. Dominance of the segment is attributed to the rising incidence of skin disorders such as acne at early ages, changing food habits, increasing levels of pollution, and a general decrease in safety levels leading to large number of trauma incidences in countries across the globe.
• In addition, increasing incidence of acne vulgaris and hospitalization cases due to trauma incidents are key factors that are expected to fuel the demand for treatment of atrophic scars. The hypertrophic scars and keloids segment is a major contributor, following the atrophic & acne scars segment, due to high patient base. For instance, according to the American Osteopathic College of Dermatology, an estimated 10% of people experience keloid scarring in the U.S.
Topical Products Segment Dominates the Market
• The report offers detailed segmentation of the global scar treatment market based on treatment type, scar type, and distribution channel. In terms of treatment type, the market has been classified into topical products [creams, gels, silicone sheets, and others (sprays, oils, etc.)], laser treatment (CO2 lasers, pulsed dye laser, and excimer laser), injectables, and others.
• The topical products segment is estimated to hold a leading share of the global market during the forecast period. Higher share of the segment is attributed to the increasing incidences of acne, primarily ice pick scars and rolling acne, which is estimated to boost the demand for topical OTC medications as well as prescription antibiotics (clindamycin, tetracycline) that are generally utilized as a first-line infection control measure.

Request for Analysis of COVID19 Impact on Scar Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=12509

Hospital Pharmacies Segment to Expand at Fastest CAGR

• Based on distribution channel, the hospital pharmacies segment accounted for a leading share of the global scar treatment market in 2018. It is projected to gain market share by the end of 2027. Some of the factors behind growth of the segment are rise in occurrence of skin problems, especially among elderly individuals.
• Additionally, advanced technologies offered by hospitals for scar treatment and reimbursement policies for various treatments and procedures drives the hospitals segment. Retail pharmacies was a prominent segment, following the hospital pharmacies segment, of the market in 2018. This is due to the rise in number of retail pharmacies and increase in medical awareness and rapid urbanization, as retail pharmacies can provide medication on customer demand. This, in turn, is likely to drive the retail pharmacies segment during the forecast period.

North America to be Highly Lucrative Market for Scar Treatment

• The scar treatment market in North America is driven by government initiatives and a highly structured health care industry. The U.S. held a major share of the market in the region, owing to the rise in geriatric population and high awareness among the people about scar treatment. Moreover, a large number of players in the U.S. are focusing on R&D in order to introduce new products. The U.S. is an early adopter of innovative products, as most pharmaceutical products are first launched in the country. This is likely to boost the market in the country in the near future. Therefore, established rules and regulations and major innovations in product development are expected to propel the scar treatment market in North America in the near future.
• The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. The scar treatment market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Buy now Scar Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=12509<ype=S

Trend of Strategic Alliance with Local Companies to Strengthen Distribution Network and Expand Geographic Presence

• The global scar treatment market is fragmented, owing to the presence of several small- and large scale companies. However, the market is dominated by a few major players with strong global presence. The report provides profiles of leading players operating in the global scar treatment market.
• Key players in the market include Valeant Pharmaceuticals International, Inc., Sonoma Pharmaceuticals, Pacific World Corporation, Merz Pharma, Sientra, Inc., Velius, LLC, CCA Industries, Inc., Mölnlycke Health Care AB (Investor AB), Fosun Pharmaceutical Co., Ltd. (Alma Lasers), Cutera, Inc., XIO Group (Lumenis), Smith & Nephew plc, and Alliance Pharma.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/need-for-efficient-drug-development-across-various-sectors-to-bring-phenomenal-growth-prospects-for-biosimulation-market-between-2020-and-2030-opines-tmr-301147587.html

https://www.prnewswire.com/news-releases/intravascular-ultrasound-ivus-devices-market-gains-from-rise-in-diagnosis-of-complex-cto-lesions-finds-tmr-301361488.html

https://www.prnewswire.com/news-releases/extensive-research-and-development-efforts-to-underscore-growth-in-photodynamic-therapy-market-from-2019-to-2027-tmr-301150981.html

Contact

TMR
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of analysts, researchers, and consultants who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods, and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

This release was published on openPR.